We observed that VILMIR was upregulated in infected or treated samples compared to mock-treated samples after RSV infection, SARS-CoV-2 infection, additional influenza infections, and IFN-β treatment (Fig. 2A). The gene discussed is IFNB1; the disease is influenza.